March 07, 2022
Mallinckrodt ARD LLC has agreed to pay $260 million to resolve government allegations that it underpaid Medicaid rebates for its Acthar gel products and paid illegal kickbacks to induce Medicare patients to buy its drugs, the U.S. Department of Justice said Monday.
June 05, 2019
The federal government claimed Wednesday that Mallinckrodt used a charitable foundation to pay kickbacks to improperly boost the prices of its anti-seizure drug H.P. Acthar Gel, joining a pair of whistleblower suits that similarly claim the company paid doctors to promote the drug.